Alnylam Pharmaceuticals, Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Alnylam Pharmaceuticals, Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Alnylam Pharmaceuticals, Inc. stocks after a simple registration process. </div>

Q: How to buy Alnylam Pharmaceuticals, Inc. shares in India?

<div> To buy Alnylam Pharmaceuticals, Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Alnylam Pharmaceuticals, Inc. and you are done!</div> </div>

Q: What is the share price of Alnylam Pharmaceuticals, Inc.?

<div>The share price of Alnylam Pharmaceuticals, Inc. is USD 189.98 as on 24 Mar.</div>

Q: What is the Market Capitalization of Alnylam Pharmaceuticals, Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Alnylam Pharmaceuticals, Inc. is USD 23.58B as on 24 Mar.</div>

Q: What is the PE ratio of Alnylam Pharmaceuticals, Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Alnylam Pharmaceuticals, Inc. is -20.90 as on 24 Mar. </div>

Q: Is Alnylam Pharmaceuticals, Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Alnylam Pharmaceuticals, Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Alnylam Pharmaceuticals, Inc. operate?

<div> Alnylam Pharmaceuticals, Inc. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$189.98

-0.51

(24 Mar)

Loading Chart

Previous close

$189.98

Open

$189.98

52W high

$242.97

15.98%

6.59%

-20.90

EPS (TTM)

-9.30

Shares O/S

124.13M

Market cap

23.58B

Insights

ALNY price is above its 200 day moving average

ALNY PE is in the top end of its range over the past 2 years

ALNY is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.

In beta. Send feedback here.

Compare with other stock

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in developing therapeutics based on ribonucleic acid interference (RNAi). Its pipeline includes five marketed products and over ten clinical programs, including several in late-stage development, across four strategic therapeutic areas (STArs): genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and CNS/ocular diseases.

Its RNAi-based medicines include ONPATTRO (patisiran), AMVUTTRA (vutrisiran), GIVLAARI (givosiran), OXLUMO (lumasiran) and Leqvio (inclisiran). ONPATTRO is an intravenously administered RNAi therapeutic targeting transthyretin amyloidosis. GIVLAARI is used to reduce induced liver aminolevulinic acid synthase 1 messenger RNA (mRNA), to reduce toxins associated with attacks and other disease manifestations of acute hepatic porphyria. OXLUMO is an RNAi therapeutic targeting hydroxyacid oxidase 1 for the treatment of primary hyperoxaluria type 1. .

FAQs

Can I buy Alnylam Pharmaceuticals, Inc. shares in India?

How to buy Alnylam Pharmaceuticals, Inc. shares in India?

What is the share price of Alnylam Pharmaceuticals, Inc.?

What is the Market Capitalization of Alnylam Pharmaceuticals, Inc.?

What is the PE ratio of Alnylam Pharmaceuticals, Inc.?

Is Alnylam Pharmaceuticals, Inc. a good stock to buy?

In which sector / industry does Alnylam Pharmaceuticals, Inc. operate?